Cargando…
Embryonic stem cells go from bench to bedside for Parkinson’s disease
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson’s disease. In preparation for clinical trial, Piao et al.(1) report on generating a clinical-grade dopaminergic progenitor cell product and its rigorous testing to ensure safety and efficacy.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080240/ https://www.ncbi.nlm.nih.gov/pubmed/33948581 http://dx.doi.org/10.1016/j.xcrm.2021.100251 |